Skip to main content

Anne-Marie Li-Kwai-Cheung

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Anne-Marie Li-Kwai-Cheung

Wave Life Sciences, Inc. reported in an 8-K filed September 26, 2022 that Anne-Marie Li-Kwai-Cheung was appointed Chief Development Officer, effective October 14, 2022.

“Effective as of October 14, 2022, Anne-Marie Li-Kwai-Cheung will be promoted to Chief Development Officer and will assume the Development responsibilities currently held by Dr. Panzara.”
Wave Life Sciences, Inc. Form 8-K, filed September 26, 2022 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Wave Life Sciences, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.